Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neoplasm, Residual × asparaginase erwinia chrysanthemi recombinant × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasm, Residual 1 Leukemia, Myeloid, Acute 1

Interventions

venetoclax 1 palbociclib 1 fludarabine 1 asparaginase erwinia chrysanthemi recombinant 1 Zymosan 1 Letrozole 1 Idarubicin 1 Etoposide 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07059975 2025-11-04

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Baylor College of Medicine

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡